Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology
Disease Category: Cancer Prevention

Trial Information

Selenium and Vitamin E Cancer Prevention Trial (SELECT)

The Queens Cancer Center of Queens Hospital Center in conjunction with the Southwest Oncology Group and sponsored by the NCI (National Cancer Institute) is participating in a 12 year national study designed to test the effectiveness of Selenium and Vitamin E in the prevention of prostate cancer. This is the largest prostate cancer prevention study ever undertaken. Approximately 32,400 men at more than 400 sites throughout the United States are expected to participate. Selenium and Vitamin E were selected for this trial because of their demonstrated anticancer activity in two other large-scale cancer prevention trials.

You may be eligible to participate in the above study if you:

• Are age 55 or older (or age 50 or older for African-American men)
• Have never been diagnosed with prostate cancer or any other cancer except non-melanoma skin cancer in the last 5 years

You may not participate in the above study if you:

• Are taking anticoagulant therapy (Coumadin)
• Have a history of stroke
• Have a history of retinitis pigmentosa (progressive degeneration of the retina of the eye)

You will not be compensated for your time, however, all FDA approved research study medication will be provided at no cost to you.

IRB APPROVAL: 8/29/02 - 8/14/03

Sharyn Parness, RN
Queens Cancer Center
Located in:
Jamaica, NY 11432
Phone: 718-883-3751
Fax: 718 883-6295
EMail: parnesss@nychhc.org

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.